片剂、口服溶液剂、混悬剂、无菌原料药(抗肿瘤药:环磷酰胺)、原料药{[抗肿瘤药:(依托泊苷、去氧氟尿苷、来曲唑、甲氨蝶呤)、(盐酸伊立替康、盐酸米托蒽醌、盐酸拓扑替康、奥沙利铂、多西他赛)、(异环磷酰胺)]、(美司那、盐酸西替利嗪、那格列奈、氯雷他定、特非那定、盐酸
中文名称 | 英文名称 | CAS | 标准 |
吡罗昔康 | Piroxicam | 36322-90-4 | |
羟基脲 | Hydroxyurea | 127-07-1 | |
环磷酰胺 | Cyclophosphamide | ||
甲苯磺丁脲 | Tolbutamide | ||
盐酸维拉帕米 | Verapamil HCl | 152-11-4 | |
藻酸双酯钠 | Alginidatum Natricum | ||
亚叶酸钙 | Leucovorin Calcium | ||
盐酸多巴酚丁胺 | Dobutamine Hydrochloride | ||
甲氨蝶呤 | Methotrexate | ||
依托咪酯 | 1-(1-phenylethyl)-imidazole-5-carboxylic acid, ethyl ester | 33125-97-2 | |
盐酸罂粟碱 | Papaverine Hydrochloride | ||
非诺洛芬钙 | Fenoprofen Calcium | ||
丙戊酸钠 | 2-Propylvaleric acid sodium salt | 1069-66-5 | |
依托泊苷 | Etoposide | 33419-42-0 | |
盐酸雷洛昔芬 | Raloxifene Hydrochloride | ||
盐酸米托蒽醌 | Mitoxantrone Hydrochloride | 70476-82-3 | |
特非那定 | Terfenadine | ||
加替沙星 | Gatifloxacin | 112811-59-3 | |
盐酸噻氯匹定 | Ticlopidine Hydrochloride | ||
盐酸伊立替康 | Irinotecan Hcl | ||
阿曲库铵苯磺酸盐 | Atracurium Besilate | ||
厄贝沙坦 | Irbesartan | 138402-11-6 | |
异环磷酰胺 | Ifosfamide | ||
盐酸左氧氟沙星 | Levofloxacine Hydrochlroide | ||
盐酸西替利嗪 | Cetirizine Di HCL | 83881-52-1 | |
唑来膦酸 | Zoledronic Acid | 118072-93-8 | |
多西他赛 | Docetaxel | ||
盐酸左布比卡因 | Levobupivacaine Hydrochloride | ||
盐酸左西替利嗪 | Levocetirizine Hydrochloride | ||
顺苯磺酸阿曲库铵 | Cisatracurium Besilate | ||
盐酸阿替卡因 | Articaine Hydrochloride | ||
盐酸氮卓斯汀 | Aselastine Hydrochloride | ||
盐酸坦洛新 | Tamsulosin Hydrochloride | ||
盐酸吡格列酮 | Pioglitazone hydrochloride | 112529-15-4 | |
加巴喷丁 | Gabapentin | 60142-96-3 | |
美司那 | Mesnaum | ||
普仑司特 | Pranlukast | 103177-37-3 | |
氯雷他定 | Loratadine | 79794-75-5 | |
盐酸氨溴索 | Ambroxol Hydrochloride | 23828-92-4 | |
克拉霉素 | Clarithromycin | 81103-11-9 | |
来曲唑 | Letrozole | 112809-51-5 | |
盐酸拓扑替康 | Topotecan Hydrochloride | 119413-54-6 | |
去氧氟尿苷 | Doxifluridine | 3094-09-5 | |
奥沙利铂 | Oxaliplatin | ||
那格列奈 | Nateglinide | 105816-04-4 | |
加替沙星 | Gatifloxacin | 112811-59-3 | |
盐酸吡格列酮 | Pioglitazone hydrochloride | 112529-15-4 | |
七氟烷 | Sevoflurane | ||
盐酸非索非那定 | Fexofenadine Hcl | ||
酒石酸布托啡诺 | Butorphanol tartrate | ||
碘佛醇 | Ioversol | 87771-40-2 |